INSTITUTE OF ANESTHESIOLOGY AND INTENSIVE THERAPY
INTRODUCTION
The patient care activities of the Institute of Anesthesiology and Intensive Therapy (AITI) is divided into three
main areas: anesthesiology, intensive therapy and pain management.
Surgery and examinations performed by doctors and anesthesiologist assistants. The annual
number of anesthesia cases exceeds 30,000. In order to reduce the fear and perioperative risk
of patients, we consider it important to thoroughly examine each patient before surgery and,
if necessary, to propose treatment changes. We practise all anaesthesia fields except cardiac
surgery anesthesia.
Our nurses work in the world-class equipped, 16-bed central intensive care unit, and also provide
their services for the 9-bed intensive care unit of the Neurosurgery Clinic. In the two departments,
we treat more than 1,600 patients every year. Our central intensive care unit is ready to receive
life-threatening patients from any hospital department.
In our institute, we already have electronic documentation in anesthesia. We perform a large number of
Continuous Renal Replacement Therapy (CRRT), and we are able to carry out Extracorporeal Membrane
Oxygenation (ECMO) treatment, too.
The pain management clinic has been receiving the patients who suffer from persistent, unbearable pain. Annually we
treat 850 patients with medication and equipment. The leader of our department is a European pain management
specialist.
Our clinical trials were performed primarily in the field of diagnosis and therapy of sepsis, and in the field of mechanical
ventilation.
Number of clinical trial investigators with Good Clinical Practice (GCP) certificate : 1
Number of clinical trial doctors with Good Clinical Practice (GCP) certificate: 1
Number of specialist doctors with Clinical Pharmacology certificate: 0
EQUIPMENT FOR CLINICAL TRIALS
- special ultrasound devices (2)
- electronic patient data management system in intensive care
- uniform, high level of development? ventilators (16 pcs.)
- elastometric hemostasis device
REFERENCE CLINICAL TRIALS
| Protocol Identifier | Name of Study | Principal Investigator |
1 | IC43-201 | Study Assessing Immunogenicity and Safety of IC43 in Intensive Care Patients | Dr. Lajos Bogár |
2 | IC43-202 | A confirmatory phase II/III study assessing efficacy… | Dr. Lajos Bogár |
3 | ART-123 | A randomized, double-blind placebo-controlled phase 3 study… | Dr. Lajos Bogár |
OUR PUBLICATIONS
Rello J, Krenn CG, Locker G, Pilger E, Madl C, Balica L, Dugernier T, Laterre PF, Spapen H, Depuydt P, Vincent JL, Bogár L, Szabó Z, Völgyes B, Máñez R, Cakar N, Ramazanoglu A, Topeli A, Mastruzzo MA, Jasovich A, Remolif CG, Del Carmen Soria L, Andresen Hernandez MA, Ruiz Balart C, Krémer I, Molnár Z, von Sonnenburg F, Lyons A, Joannidis M, Burgmann H, Welte T, Klingler A, Hochreiter R, Westritschnig K. A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients. Critical Care. 2017 Feb 4;21(1):22. doi: 10.1186/s13054-017-1601-9.
Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF; EUROBACT Investigators. Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey. Critical Care. 2013 Dec 10;17(6):R289. doi: 10.1186/cc13153.
Breen D, Bogar L, Heigl P, Rittberger J, Shorten GD. Validation of a clinical assessment tool for spinal anaesthesia. Acta Anaesthesiology Scandinavica. 2011 Jul;55(6):653-7. doi: 10.1111/j.1399-6576.2011.02433.x.
Toth K, Bogar L, Juricskay I, Keltai M, Yusuf S, Haywood LJ, Meiselman HJ. The effect of RheothRx Injection on the hemorheological parameters in patients with acute myocardial infarction. Clinical Hemorheology and Microcirculation. 1997 Mar-Apr;17(2):117-25.
Walker RT, Matrai A, Bogar L, Dormandy JA. Serotonin and the flow properties of blood. Journal os Cardiovascular Pharmacology. 1985;7 Suppl 7:S35-7.
Gondos T, Marjanek Z, Ulakcsai Z, Szabó Z, Bogár L, Károlyi M, Gartner B, Kiss K, Havas A, Futó J. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. European Journal of Anaesthesiology. 2010 Sep;27(9):794-800. doi: 10.1097/EJA.0b013e32833b3504.
PRINCIPAL INVESTIGATORS
Dr. Lajos Bogár | ![]()
|
SCIENTIFIC DEGREE | D.Sc. |
POSITION | University Professor |
QUALIFICATIONS | Anesthesiology and Intensive Care |
SCIENTIFIC INTEREST | Anesthesiology, Intensive Therapy |
REFERENCE CLINICAL TRIALS | IC43-201, number of patients included: 11 IC43-202, number of patients included: 5 ART-123, number of patients enrolled: 0 |
| AVAILABLE FOR PERFORMING CLINICAL TRIALS | Phase 3-4 |
Dr. Krisztián Jáksó |
|
SCIENTIFIC DEGREE | n.a. |
POSITION | Chief Clinical Physician |
QUALIFICATIONS | Anesthesiology and Intensive Care |
SCIENTIFIC INTEREST | Intensive Therapy |
REFERENCIA VIZSGÁLATOK | IC43-201, bevont betegek száma: 11 IC43-202, bevont betegek száma: 5 ART-123, bevont betegek száma: 0 |
| AVAILABLE FOR PERFORMING CLINICAL TRIALS | Phase 3-4 |
STUDY TEAM
The clinic currently does not have its own coordinator and study nurse. You need to contact
the Coordination Centre for Clinical Trials (KVKK).
References
[1] https://www.ncbi.nlm.nih.gov/pubmed/28159015 [2] https://www.ncbi.nlm.nih.gov/pubmed/24326145 [3]
https://www.ncbi .nlm.nih.gov/pubmed/9255435 [4] https://www.ncbi.nlm.nih.gov/pubmed/2412054 [5]
https://www.ncbi.nlm.nih.gov/pubmed/20520555
Létrehozva: 2019.08.21.
Utoljára frissítve: 2019.09.04.

